Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels.
about
Multifaceted role of β-arrestins in inflammation and diseaseAdrenal G protein-coupled receptor kinase-2 in regulation of sympathetic nervous system activity in heart failureRisk of acute myocardial infarction after transurethral resection of prostate in elderlyArrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis.The contributions of muscarinic receptors and changes in plasma aldosterone levels to the anti-hypertensive effect of Tulbaghia violaceaSuppression of adrenal βarrestin1-dependent aldosterone production by ARBs: head-to-head comparison.GRK2 and β-arrestins in cardiovascular disease: Something old, something new.Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2) -adrenoceptor-catecholamine production axis in heart failureStructure-activity relationship study of angiotensin II analogs in terms of β-arrestin-dependent signaling to aldosterone production.Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic studyCurrent and future G protein-coupled receptor signaling targets for heart failure therapyAdrenergic nervous system in heart failure: pathophysiology and therapy.Neuro-hormonal effects of physical activity in the elderly.βArrestins in cardiac G protein-coupled receptor signaling and function: partners in crime or "good cop, bad cop"?Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms.Arrestin-biased AT1R agonism induces acute catecholamine secretion through TRPC3 coupling.Pharmacogenomics of the heptahelical receptor regulators G-protein-coupled receptor kinases and arrestins: the known and the unknown.Molecular aspects of the cardioprotective effect of exercise in the elderly.Adrenal adrenoceptors in heart failure.Tailoring therapy for heart failure: the pharmacogenomics of adrenergic receptor signaling.Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy.Prothymosin alpha protects cardiomyocytes against ischemia-induced apoptosis via preservation of Akt activation.β1-adrenoceptor Arg389Gly polymorphism confers differential β-arrestin-binding tropism in cardiac myocytes.Long-Term Caloric Restriction Improves Cardiac Function, Remodeling, Adrenergic Responsiveness, and Sympathetic Innervation in a Model of Postischemic Heart Failure.New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and AgingMicroRNA-204 Is Necessary for Aldosterone-Stimulated T-Type Calcium Channel Expression in Cardiomyocytes
P2860
Q26785883-47B2DCD6-2D00-4060-A29B-8D5AF168B51AQ26785936-0D669D4F-D1CA-4DEB-A24D-34B8355D1725Q26859700-4B414F9D-8260-48FF-830A-1636FDC9BE65Q34249203-E601012A-260E-4C4A-9C19-FD8D28560C04Q34545558-1F6944CD-2326-4B88-A9E3-AD59899622BBQ35024828-69093381-01F0-4A63-ABEF-570D99A15D87Q35660111-08E4DD2C-B255-4CC9-84EC-A9E830103BCBQ36252811-909F2252-E312-463B-81AE-57C1867E5280Q36719641-073F3100-A880-4E81-B19F-B5224D91CF93Q37022630-7565E833-511D-4EE7-BAF2-ECFFDF416216Q37232104-D906F080-5939-4B31-8BE0-28BFAA804C1FQ37349756-2E49E2CD-DBD2-442B-8002-ADFB88526B13Q37404953-03D83EFE-8BEE-4A0E-B96B-2CC345232AE9Q37421052-6BE16CCB-0AD5-41A1-AE52-84D7AF70195EQ37470858-C8C60659-7D81-480E-88DE-0E8789AC6375Q37642774-BF64ACEA-29F8-4A2F-BA2A-3A6CB724F1DDQ37981274-0A85721A-0ECA-4942-9A3B-B94A494D8265Q38129354-D645A910-3C2D-4275-9035-468D6F3A84A2Q38234911-76DBEAA2-F8BB-49A8-9630-1770F4F4AA8AQ38256143-7A43048F-38BA-40FC-936A-B9B5140E9F5AQ42371966-D17E6CD1-CDB9-41EC-BAF4-E848C5A34CC4Q48001415-090DC6A2-E58B-4C49-974F-5BD70A68DF84Q51490785-B17F6DD8-6752-479E-8E7E-D77C9DD89618Q51740622-2D1BDE5E-6287-4B75-AE30-0A2FE0D15D1FQ58790122-D7019B04-5C9A-4AF5-A5CE-5C748D0F25E4Q59138407-76292993-C81E-4492-A447-19AE2092E281
P2860
Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Adrenal beta-arrestin 1 inhibi ...... irculating aldosterone levels.
@ast
Adrenal beta-arrestin 1 inhibi ...... irculating aldosterone levels.
@en
Adrenal beta-arrestin 1 inhibi ...... irculating aldosterone levels.
@nl
type
label
Adrenal beta-arrestin 1 inhibi ...... irculating aldosterone levels.
@ast
Adrenal beta-arrestin 1 inhibi ...... irculating aldosterone levels.
@en
Adrenal beta-arrestin 1 inhibi ...... irculating aldosterone levels.
@nl
prefLabel
Adrenal beta-arrestin 1 inhibi ...... irculating aldosterone levels.
@ast
Adrenal beta-arrestin 1 inhibi ...... irculating aldosterone levels.
@en
Adrenal beta-arrestin 1 inhibi ...... irculating aldosterone levels.
@nl
P2860
P50
P1476
Adrenal beta-arrestin 1 inhibi ...... irculating aldosterone levels.
@en
P2093
Walter J Koch
P2860
P304
P356
10.1016/J.JACC.2010.08.635
P407
P577
2011-01-01T00:00:00Z